Overview

Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

Status:
RECRUITING
Trial end date:
2027-06-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety, tolerability, and effect on mucosal repair of AZD7798 compared with placebo in participants with active ileal Crohn's disease and an ileostomy.
Phase:
PHASE2
Details
Lead Sponsor:
AstraZeneca